|Systematic (IUPAC) name|
|AHFS/Drugs.com||Multum Consumer Information|
|ATC code||L01XD03 (WHO)|
|Molar mass||145.156 g/mol|
|(what is this?)|
Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser.
Approvals and indications
It has been reported as controversial in some quarters, with severe pain allegedly being experienced by some patients. 
- http://photocure.com/NEWS/newcontainer/Photocure-divests-Metvix-to-Galderma-for-EUR-51-million/ Photocure divests Metvix to Galderma
- http://dermnetnz.org/procedures/metvix-pdt.html "Methyl aminolevulinate photodynamic therapy (MAL PDT)"
- http://www.medicalnewstoday.com/articles/36953.php "New 5 Year Metvix-PDT Data Demonstrate Long-Term Efficacy & Reliability For NM Skin Cancer Treatment" 2006
- http://findarticles.com/p/articles/mi_qa3931/is_200909/ai_n42040200/pg_13/[dead link] Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy Photochemistry and Photobiology, Sep/Oct 2009 by O'Connor, Aisling E, Gallagher, William M, Byrne, Annette T
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|